Atlas Trials

Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia

Clinical trial NCT02108132 · UNKNOWN

Trial details

NCT number
NCT02108132
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hemophilia
Start date
2014-08-01
Primary completion
2015-08-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.